期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
Management of gastro-esophageal reflux disease:Practice-oriented answers to clinical questions
1
作者 leonardo frazzoni Lorenzo Fuccio Rocco Maurizio Zagari 《World Journal of Gastroenterology》 SCIE CAS 2023年第5期773-779,共7页
Gastro-esophageal reflux disease(GERD)is a condition which is frequently faced by primary care physicians and gastroenterologists.Improving management of GERD is crucial to maximise both patient care and resource util... Gastro-esophageal reflux disease(GERD)is a condition which is frequently faced by primary care physicians and gastroenterologists.Improving management of GERD is crucial to maximise both patient care and resource utilization.In fact,the management of patients with GERD is complex and poses several questions to the clinician who faces them in clinical practice.For instance,many aspects should be considered,including the appropriateness of indication to endoscopy,the quality of the endoscopic examination,the use and interpretation of ambulatory reflux testing,and the choice and management of anti-reflux treatments,i.e.,protonpump inhibitors and surgery.Aim of the present review was to provide a comprehensive update on the clinical management of patients with GERD,through a literature review on the diagnosis and management of patients with GER symptoms.In details,we provide practice-oriented concise answers to clinical questions,with the aim of optimising patient management and healthcare resource use. 展开更多
关键词 Gastro-esophageal reflux disease Diagnosis MANAGEMENT Proton-pump inhibitor
下载PDF
Laparoscopic fundoplication for gastroesophageal reflux disease 被引量:15
2
作者 Marzio frazzoni Micaela Piccoli +2 位作者 Rita Conigliaro leonardo frazzoni Gianluigi Melotti 《World Journal of Gastroenterology》 SCIE CAS 2014年第39期14272-14279,共8页
Gastroesophageal reflux disease (GERD) is a condition that develops when the reflux of gastric contents into the esophagus leads to troublesome symptoms and/or complications. Heartburn is the cardinal symptom, often a... Gastroesophageal reflux disease (GERD) is a condition that develops when the reflux of gastric contents into the esophagus leads to troublesome symptoms and/or complications. Heartburn is the cardinal symptom, often associated with regurgitation. In patients with endoscopy-negative heartburn refractory to proton pump inhibitor (PPI) therapy and when the diagnosis of GERD is in question, direct reflux testing by impedance-pH monitoring is warranted. Laparoscopic fundoplication is the standard surgical treatment for GERD. It is highly effective in curing GERD with a 80% success rate at 20-year follow-up. The Nissen fundoplication, consisting of a total (360&#x000b0;) wrap, is the most commonly performed antireflux operation. To reduce postoperative dysphagia and gas bloating, partial fundoplications are also used, including the posterior (Toupet) fundoplication, and the anterior (Dor) fundoplication. Currently, there is consensus to advise laparoscopic fundoplication in PPI-responsive GERD only for those patients who develop untoward side-effects or complications from PPI therapy. PPI resistance is the real challenge in GERD. There is consensus that carefully selected GERD patients refractory to PPI therapy are eligible for laparoscopic fundoplication, provided that objective evidence of reflux as the cause of ongoing symptoms has been obtained. For this purpose, impedance-pH monitoring is regarded as the diagnostic gold standard. 展开更多
关键词 Gastroesophageal reflux disease Refractory gastroesophageal reflux disease Laparoscopic fundoplication Impedance-pH monitoring Proton pump inhibitors
下载PDF
Prevention of pelvic radiation disease 被引量:7
3
作者 Lorenzo Fuccio leonardo frazzoni Alessandra Guido 《World Journal of Gastrointestinal Pharmacology and Therapeutics》 CAS 2015年第1期1-9,共9页
Pelvic cancers are among the most frequently diagnosed cancers worldwide. Treatment of patients requires a multidisciplinary approach that frequently includes radiotherapy. Gastrointestinal(GI) radiation-induced toxic... Pelvic cancers are among the most frequently diagnosed cancers worldwide. Treatment of patients requires a multidisciplinary approach that frequently includes radiotherapy. Gastrointestinal(GI) radiation-induced toxicity is a major complication and the transient or long-term problems, ranging from mild to very severe, arising in non-cancerous tissues resulting from radiation treatment to a tumor of pelvic origin, are actually called as pelvic radiation disease. The incidence of pelvic radiation disease changes according to the radiation technique, the length of follow up, the assessmentmethod, the type and stage of cancer and several other variables. Notably, even with the most recent radiation techniques, i.e., intensity-modulated radiotherapy, the incidence of radiation-induced GI side effects is overall reduced but still not negligible. In addition, radiation-induced GI side effects can develop even after several decades; therefore, the improvement of patient life expectancy will unavoidably increase the risk of developing radiation-induced complications. Once developed, the management of pelvic radiation disease may be challenging. Therefore, the prevention of radiation-induced toxicity represents a reasonable way to avoid a dramatic drop of the quality of life of these patients. In the current manuscript we provide an updated and practical review on the best available evidences in the field of the prevention of pelvic radiation disease. 展开更多
关键词 Pelvic radiation DISEASE Radiotherapy Gastrointestinal toxicity AMIFOSTINE AMINOSALICYLATES Sucralfate BECLOMETHASONE dipropionate Probiotics supplementation MISOPROSTOL MESALAZINE
下载PDF
Pelvic radiation disease:Updates on treatment options 被引量:3
4
作者 leonardo frazzoni Marina La Marca +3 位作者 Alessandra Guido Alessio Giuseppe Morganti Franco Bazzoli Lorenzo Fuccio 《World Journal of Clinical Oncology》 CAS 2015年第6期272-280,共9页
Pelvic cancers are among the most frequently diagnosed neoplasms and radiotherapy represents one of the main treatment options. The irradiation field usually encompasses healthy intestinal tissue,especially of distal ... Pelvic cancers are among the most frequently diagnosed neoplasms and radiotherapy represents one of the main treatment options. The irradiation field usually encompasses healthy intestinal tissue,especially of distal large bowel,thus inducing gastrointestinal(GI) radiation-induced toxicity. Indeed,up to half of radiationtreated patients say that their quality of life is affected by GI symptoms(e.g.,rectal bleeding,diarrhoea). The constellation of GI symptoms- from transient to longterm,from mild to very severe- experienced by patients who underwent radiation treatment for a pelvic tumor have been comprised in the definition of pelvic radiation disease(PRD). A correct and evidence-based therapeutic approach of patients experiencing GI radiation-induced toxicity is mandatory. Therapeutic non-surgical strategies for PRD can be summarized in two broad categories,i.e.,medical and endoscopic. Of note,most of the studies have investigated the management of radiation-induced rectal bleeding. Patients with clinically significant bleeding(i.e.,causing chronic anemia) should firstly be considered for medical management(i.e.,sucralfate enemas,metronidazole and hyperbaric oxygen); in case of failure,endoscopic treatment should be implemented. This latter should be considered the first choice in case of acute,transfusion requiring,bleeding. More well-performed,high quality studies should be performed,especially the role of medical treatments should be better investigated as well as the comparative studies between endoscopic and hyperbaric oxygen treatments. 展开更多
关键词 PELVIC radiation DISEASE RADIATION-INDUCED proctopathy Radiotherapy Gastrointestinal toxicity Sucralfate METRONIDAZOLE Probiotics Argon plasma coagulation HYPERBARIC oxygen FORMALIN
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部